long acting Injection [Design Issues]

posted by jag009  – NJ, 2020-04-21 23:06 (1464 d 18:19 ago) – Posting: # 21342
Views: 1,633

Hi,

❝ But if it is mentioned in monograph that half-life is 17 days following single dose and 46 days after multiple dose, then which half-life we should consider while designing multiple dose study? In the same monograph, it is also stated that steady state is achieved after 4th dose on injection.


Have you found out why the increase in half-life?

J

Complete thread:

UA Flag
Activity
 Admin contact
22,993 posts in 4,828 threads, 1,651 registered users;
96 visitors (0 registered, 96 guests [including 5 identified bots]).
Forum time: 17:26 CEST (Europe/Vienna)

Never never never never use Excel.
Not even for calculation of arithmetic means.    Martin Wolfsegger

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5